Compare Johnson & Johnson (JNJ) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Moderna, Inc. — how do they compare? Johnson & Johnson trades at $250.66 (market cap $598.96B), while Moderna, Inc. trades at $59.73 (market cap $23.60B). The key difference: Johnson & Johnson is far larger — about 25.4× Moderna, Inc.'s market cap, and Johnson & Johnson pays a 2.15% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| JNJ | MRNA | |
|---|---|---|
Market Cap | $598.96B | $23.60B |
Volume | 6,156,228 | — |
Sector | Health | Health |
52-Week High | $267.24 | $81.80 |
52-Week Low | $164.36 | $22.36 |
Enterprise Value | $631.90B | $19.70B |
Dividend Yield | 2.15% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
